BlueOcean NutraSciences CEO Transition

The Board of Directors of BlueOcean NutraSciences (TSX VENTURE:BOC) announce the
appointment of Mr. Gavin Bogle as BlueOceans' interim CEO effective immediately,
replacing Doug Kemp-Welch who will stay as an Advisor until September 8, 2014.
Mr. Bogle will remain a director of BlueOcean. Gavin will lead BlueOcean in the
next phase of its development after Doug repositioned the company as a specialty
producer of oils for the nutraceutical and pharmaceutical industries. 


Gavin has more than 20 years of executive, consulting, and legal experience in
the nutraceutical and pharmaceutical industries in both the US and Canada. He
has an M.Sc. in microbiology and molecular biology, a law degree and an MBA.
Gavin has extensive licensing, intellectual property, and corporate experience
that BlueOcean will benefit from. 


The Board would like to thank Doug Kemp-Welch for his major contributions as CEO
of BlueOcean (formerly called Solutions4CO2) over the last four years and wish
him success in the future.


About BlueOcean NutraSciences

BlueOcean is a Canadian company that develops specialty oils using innovative
product platforms targeted at the rapidly growing health and Wellness and Animal
Feed markets. 


BlueOcean is developing three specialty oil products: AstaShrimp, AlgaOmega and
AstaTene. BlueOcean owns 50% of the participating and voting rights in 70717
Newfoundland and Labrador Ltd, a joint venture with a major Atlantic Canada
shrimp processor that provides the shrimp feedstock for the extraction of
AstaShrimp, and 50% of Asta NutraSciences Inc., a company formed to develop
natural astaxanthin based health and wellness products for the nutraceutical and
animal feed markets. BlueOcean wholly owns its AlgaOmega product line. 


Forward Looking Statements

This news release may contain forward-looking statements that are based on
BlueOcean's expectations, estimates and projections regarding its business and
the economic environment in which it operates. These statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to control or predict. Therefore, actual outcomes and results may
differ materially from those expressed in these forward-looking statements and
readers should not place undue reliance on such statements. Statements speak
only as of the date on which they are made, and the Company undertakes no
obligation to update them publicly to reflect new information or the occurrence
of future events or circumstances, unless otherwise required to do so by law.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
BlueOcean NutraSciences
Gavin Bogle
Interim CEO
416-970-3266


BlueOcean NutraSciences
Dil Vashi
Manager Corporate Development
416-803-9435 extension 104
www.blueoceannutra.ca